COPD

With the wide selection of available inhalers, this article sheds light on factors that can influence COPD treatment success.

Most people hear "hospice" and think "cancer," but many end-stage chronic obstructive pulmonary disease patients also receive hospice care when their caregivers can no longer provide the medical attention they need.

A new start-up is looking to integrate smart sensors into current inhalers to increase adherence.

A healthy diet associated with reduced heart disease risk may also lower the risk of chronic obstructive pulmonary disease.

Symptoms include airflow obstruction, bronchial hyperresponsiveness, and airway inflammation.

See a new technique to treat severe asthma.

An examination of the pathophysiology of asthma.

Phase 3 registrational studies of TD-4208 are anticipated to begin in 2015

A review of the pathology of asthma and COPD, including the role of the immune system, along with the mechanisms behind the hypercapnia and hypoxemia of COPD, and the blue bloater vs. pink puffer pseudodichotomy.

Patients with chronic obstructive pulmonary disease who consume beetroot juice have less trouble exercising.

Novartis announced that it has submitted New Drug Applications to the FDA for QVA149 and NVA237, investigational drugs for the long-term maintenance treatment of chronic obstructive pulmonary disease, following positive results from phase 3 trials of the drugs.

Rhinovirus infection tends to aggravate other conditions in the elderly.

Tiotropium, a once-daily inhaled long-acting anticholinergic bronchodilator, provides airflow improvement for at least 24 hours in chronic obstructive pulmonary disease patients. Its use has been linked to fewer exacerbations, less dyspnea, and improved quality of life.

Patients with bronchial asthma or chronic obstructive pulmonary disease fare best with metered dose inhalers that have spacer devices.

Vitamin D supplements can reduce the severity and duration of chronic obstructive pulmonary disease flare-ups by more than 40%.

In a study of patients with comorbid COPD and metabolic syndrome, elevated triglyceride levels were associated with increased mortality rates.

The FDA is reviewing a regulatory application to add an asthma indication to Boehringer Ingelheim's chronic obstructive pulmonary disease treatment, tiotropium bromide.

AstraZeneca today announced that it has completed the strategic transaction to transfer the rights to Almirall's respiratory franchise to the company.

New guidelines prioritize treatment options and preventive therapies for reducing the risk of COPD exacerbations in at-risk patients.

Even though smoking can exacerbate respiratory conditions and limit the efficacy of their treatment, patients often purchase cigarettes while filling prescriptions for asthma or antihypertensive drugs at pharmacies.

The disease burden of smoking remains immense despite widespread tobacco cessation efforts.

Coaching patients with chronic obstructive pulmonary disease on relaxation techniques can improve their quality of life and even ease their symptoms.

Combining 2 classes of COPD medications leads to better outcomes for older adults with comorbid asthma.

Program featuring care transition pharmacists shown to reduce hospital readmissions, improve patient satisfaction.

A recent article suggests that comparing 2 or more observations of a patient's COPD symptoms over time can help clinicians learn why patients lose control of the disease.

Study finds higher risk of cardiovascular and cerebrovascular disease in COPD patients, suggests spread of inflammation may be a factor.

Hospitalization rates for chronic obstructive pulmonary disease were found to be lower in communities that have smoke-free policies.

COPD patients who engaged in any amount of moderate to vigorous physical activity after hospitalization had significantly reduced rates of readmission, according to the results of a new study.